Sean Laaman
Stock Analyst at Morgan Stanley
(4.73)
# 124
Out of 5,090 analysts
18
Total ratings
88.24%
Success rate
22.62%
Average return
Main Sectors:
Stocks Rated by Sean Laaman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MPLT MapLight Therapeutics | Initiates: Overweight | $34 | $17.90 | +89.94% | 1 | Nov 21, 2025 | |
| EXEL Exelixis | Maintains: Overweight | $44 → $45 | $44.16 | +1.90% | 4 | Nov 5, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Overweight | $194 → $196 | $151.04 | +29.77% | 3 | Nov 4, 2025 | |
| IRON Disc Medicine | Maintains: Overweight | $90 → $115 | $95.00 | +21.05% | 3 | Oct 30, 2025 | |
| RMD ResMed | Maintains: Overweight | $298 → $304 | $254.78 | +19.32% | 2 | Oct 21, 2025 | |
| ONC BeOne Medicines AG | Maintains: Overweight | $350 → $383 | $318.74 | +20.16% | 2 | Oct 20, 2025 | |
| CERT Certara | Assumes: Equal-Weight | $16 | $9.48 | +68.78% | 1 | Jul 3, 2025 | |
| ALEC Alector | Assumes: Underweight | $3 → $1.5 | $1.20 | +25.00% | 1 | Mar 7, 2025 | |
| HALO Halozyme Therapeutics | Assumes: Overweight | $67 | $63.48 | +5.55% | 1 | Feb 14, 2025 |
MapLight Therapeutics
Nov 21, 2025
Initiates: Overweight
Price Target: $34
Current: $17.90
Upside: +89.94%
Exelixis
Nov 5, 2025
Maintains: Overweight
Price Target: $44 → $45
Current: $44.16
Upside: +1.90%
Axsome Therapeutics
Nov 4, 2025
Maintains: Overweight
Price Target: $194 → $196
Current: $151.04
Upside: +29.77%
Disc Medicine
Oct 30, 2025
Maintains: Overweight
Price Target: $90 → $115
Current: $95.00
Upside: +21.05%
ResMed
Oct 21, 2025
Maintains: Overweight
Price Target: $298 → $304
Current: $254.78
Upside: +19.32%
BeOne Medicines AG
Oct 20, 2025
Maintains: Overweight
Price Target: $350 → $383
Current: $318.74
Upside: +20.16%
Certara
Jul 3, 2025
Assumes: Equal-Weight
Price Target: $16
Current: $9.48
Upside: +68.78%
Alector
Mar 7, 2025
Assumes: Underweight
Price Target: $3 → $1.5
Current: $1.20
Upside: +25.00%
Halozyme Therapeutics
Feb 14, 2025
Assumes: Overweight
Price Target: $67
Current: $63.48
Upside: +5.55%